LIVIVO - Search results -

Search results

Result 1 - 10 of total 78

Search options

Article: Pregnancy-related healthcare utilization among women with multiple sclerosis.

Mainguy, Marie / Le Page, Emmanuelle / Michel, Laure / Leray, Emmanuelle

2023 Volume 14, Page(s) 1129117

Abstract: Introduction: Many studies have investigated pregnancy in women with multiple sclerosis (MS). However, no study has measured prenatal healthcare utilization in women with MS or adherence to follow-up recommendations to improve antenatal care quality. A ... ...

Abstract	Introduction: Many studies have investigated pregnancy in women with multiple sclerosis (MS). However, no study has measured prenatal healthcare utilization in women with MS or adherence to follow-up recommendations to improve antenatal care quality. A better knowledge of the quality of antenatal care in women with MS would help identify and better support women with insufficient follow-up. Our objective was to measure the level of compliance to prenatal care recommendations in women with MS using data from the French National Health Insurance Database. Methods: This retrospective cohort study included all pregnant women with MS who gave live birth in France between 2010 and 2015. Using the French National Health Insurance Database, follow-up visits with gynecologists, midwives, and general practitioners (GPs) were identified, as well as ultrasound exams and laboratory tests. Based on the Adequacy of Prenatal Care Use and Content and Timing of care in Pregnancy indices, a new tool adapted to the French recommendations was developed to measure and classify the antenatal care trajectory (adequate or inadequate). Explicative factors were identified using multivariate logistic regression models. A random effect was included because women may have had more than one pregnancy during the study period. Results: In total, 4,804 women with MS ( Discussion: Many women consulted their GP during pregnancy. This could be linked to a low density of gynecologists but may also reflect the preferences of women. Our findings can help adapt recommendations and healthcare providers' practices according to the women's profiles.
Language	English
Publishing date	2023-02-16
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2564214-5
ISSN	1664-2295
ISSN	1664-2295
DOI	10.3389/fneur.2023.1129117
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Comment parler d’un événement grave à un enfant ?

Leray, Marie / Vila, Gilbert

La Revue du praticien

2020 Volume 70, Issue 4, Page(s) 444–446

Abstract: How to talk about a serious event to a child? Talking to a child about a serious event is difficult. Should we be afraid of causing him trauma? We will present two clinical situations each involving a pedophile father. The contrasting evolutions make it ... ...

Title translation	How to talk about a serious event to a child?
Abstract	How to talk about a serious event to a child? Talking to a child about a serious event is difficult. Should we be afraid of causing him trauma? We will present two clinical situations each involving a pedophile father. The contrasting evolutions make it possible to highlight the important elements to be taken into account in this type of situation, by insisting on the variables relating to the child rather than the pressure that can be put by the entourage and the urgency of the event. Then, we will discuss the case of the death of a loved one and an other on the announcement to a child of a collective disaster: the spread of the Covid-19.
MeSH term(s)	Betacoronavirus ; COVID-19 ; Child ; Communication ; Coronavirus Infections ; Death ; Family ; Humans ; Pandemics ; Parent-Child Relations ; Pedophilia ; Pneumonia, Viral ; Psychology, Child ; SARS-CoV-2
Keywords	covid19
Language	French
Publishing date	2020-09-02
Publishing country	France
Document type	Journal Article
ZDB-ID	205365-2
ISSN	2101-017X ; 0035-2640
ISSN (online)	2101-017X
ISSN	0035-2640
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.433: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: [How to talk about a serious event to a child?]

Leray, Marie / Vila, Gilbert

Rev Prat

Abstract: How to talk about a serious event to a child? Talking to a child about a serious event is difficult Should we be afraid of causing him trauma? We will present two clinical situations each involving a pedophile father The contrasting evolutions make it ... ...

Abstract	How to talk about a serious event to a child? Talking to a child about a serious event is difficult Should we be afraid of causing him trauma? We will present two clinical situations each involving a pedophile father The contrasting evolutions make it possible to highlight the important elements to be taken into account in this type of situation, by insisting on the variables relating to the child rather than the pressure that can be put by the entourage and the urgency of the event Then, we will discuss the case of the death of a loved one and an other on the announcement to a child of a collective disaster: the spread of the Covid-19
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #739579
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Combined SPT and FCS methods reveal a mechanism of RNAP II oversampling in cell nuclei.

Fournier, Marie / Leclerc, Pierre / Leray, Aymeric / Champelovier, Dorian / Agbazahou, Florence / Dahmani, Fatima / Bidaux, Gabriel / Furlan, Alessandro / Héliot, Laurent

Scientific reports

2023 Volume 13, Issue 1, Page(s) 14633

Abstract: Gene expression orchestration is a key question in fundamental and applied research. Different models for transcription regulation were proposed, yet the dynamic regulation of RNA polymerase II (RNAP II) activity remains a matter of debate. To improve ... ...

Abstract	Gene expression orchestration is a key question in fundamental and applied research. Different models for transcription regulation were proposed, yet the dynamic regulation of RNA polymerase II (RNAP II) activity remains a matter of debate. To improve our knowledge of this topic, we investigated RNAP II motility in eukaryotic cells by combining single particle tracking (SPT) and fluorescence correlation spectroscopy (FCS) techniques, to take advantage of their different sensitivities in order to analyze together slow and fast molecular movements. Thanks to calibrated samples, we developed a benchmark for quantitative analysis of molecular dynamics, to eliminate the main potential instrumental biases. We applied this workflow to study the diffusion of RPB1, the catalytic subunit of RNAP II. By a cross-analysis of FCS and SPT, we could highlight different RPB1 motility states and identifyed a stationary state, a slow diffusion state, and two different modes of subdiffusion. Interestingly, our analysis also unveiled the oversampling by RPB1 of nuclear subdomains. Based on these data, we propose a novel model of spatio-temporal transcription regulation. Altogether, our results highlight the importance of combining microscopy approaches at different time scales to get a full insight into the real complexity of molecular kinetics in cells.
MeSH term(s)	RNA Polymerase II ; Single Molecule Imaging ; Cell Nucleus ; Transcription, Genetic ; Microscopy
Chemical Substances	RNA Polymerase II (EC 2.7.7.-)
Language	English
Publishing date	2023-09-05
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2615211-3
ISSN	2045-2322 ; 2045-2322
ISSN (online)	2045-2322
ISSN	2045-2322
DOI	10.1038/s41598-023-38668-8
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years-Protocol, recruitment status, and baseline characteristics.

Vukusic, Sandra / Bourre, Bertrand / Casey, Romain / Deiva, Kumaran / Guennoc, Anne-Marie / Lebrun-Frenay, Christine / Leray, Emmanuelle / Rollot, Fabien / Benyahya, Lakhdar / Girod, Catherine / Marignier, Romain / Maillart, Elisabeth

Multiple sclerosis (Houndmills, Basingstoke, England)

2024 Volume 30, Issue 2, Page(s) 216–226

Abstract: Background: Counseling on pregnancy is still challenging, particularly regarding the use of disease-modifying treatments (DMTs). We are lacking long-term outcomes in children exposed to DMTs.: Objectives: This study aimed to set up a French pregnancy ...

Abstract	Background: Counseling on pregnancy is still challenging, particularly regarding the use of disease-modifying treatments (DMTs). We are lacking long-term outcomes in children exposed to DMTs. Objectives: This study aimed to set up a French pregnancy registry for women with multiple sclerosis (MS) and related disorders nested within the Observatoire Français de la Sclérose en Plaques (OFSEP) cohort. Methods: Prospective, observational, multicentric, epidemiological study in France. Neurological visits are organized according to routine practice. Data are collected on the OFSEP minimal datasheet. Auto-questionnaires on pregnancy are completed by patients at Months 5-6 and 8 during pregnancy, and Months 3, 6, and 12 postpartum. A specific survey on analgesia is completed by anesthesiologists. Pediatric data are collected from the child's health book, where visits on Day 8, Month 9, and 24 are mandatory. Parents complete neurodevelopmental questionnaires at Year 1, Years 2 and 6. Results: The RESPONSE study started in August 2019. On 7 April 2023, 515 women were included. Baseline demographics are presented. Conclusions: RESPONSE will provide rich information on the global management of pregnancy in France and prospective data on children until the age of 6 years, exposed or not to a DMT, including data on neurodevelopment that can be compared to the general population. Study funding: EDMUS and ARSEP Foundation, Biogen, Roche.
MeSH term(s)	Child ; Female ; Humans ; Pregnancy ; France/epidemiology ; Multiple Sclerosis/epidemiology ; Multiple Sclerosis/therapy ; Postpartum Period ; Prospective Studies ; Registries
Language	English
Publishing date	2024-01-11
Publishing country	England
Document type	Journal Article ; Multicenter Study ; Observational Study
ZDB-ID	1290669-4
ISSN	1477-0970 ; 1352-4585
ISSN (online)	1477-0970
ISSN	1352-4585
DOI	10.1177/13524585231223390
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4428: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Assessing environmental epidemiology questions in practice with a causal inference pipeline: An investigation of the air pollution-multiple sclerosis relapses relationship.

Sommer, Alice J / Leray, Emmanuelle / Lee, Young / Bind, Marie-Abèle C

Statistics in medicine

2020 Volume 40, Issue 6, Page(s) 1321–1335

Abstract: When addressing environmental health-related questions, most often, only observational data are collected for ethical or practical reasons. However, the lack of randomized exposure often prevents the comparison of similar groups of exposed and unexposed ... ...

Abstract	When addressing environmental health-related questions, most often, only observational data are collected for ethical or practical reasons. However, the lack of randomized exposure often prevents the comparison of similar groups of exposed and unexposed units. This design barrier leads the environmental epidemiology field to mainly estimate associations between environmental exposures and health outcomes. A recently developed causal inference pipeline was developed to guide researchers interested in estimating the effects of plausible hypothetical interventions for policy recommendations. This article illustrates how this multistaged pipeline can help environmental epidemiologists reconstruct and analyze hypothetical randomized experiments by investigating whether an air pollution reduction intervention decreases the risk of multiple sclerosis relapses in Alsace region, France. The epidemiology literature reports conflicted findings on the relationship between air pollution and multiple sclerosis. Some studies found significant associations, whereas others did not. Two case-crossover studies reported significant associations between the risk of multiple sclerosis relapses and the exposure to air pollutants in the Alsace region. We use the same study population as these epidemiological studies to illustrate how appealing this causal inference approach is to estimate the effects of hypothetical, but plausible, environmental interventions.
MeSH term(s)	Air Pollutants/analysis ; Air Pollution/adverse effects ; Air Pollution/analysis ; Environmental Exposure/adverse effects ; Environmental Exposure/analysis ; Environmental Health ; France/epidemiology ; Humans ; Multiple Sclerosis/epidemiology ; Multiple Sclerosis/etiology ; Particulate Matter ; Recurrence
Chemical Substances	Air Pollutants ; Particulate Matter
Language	English
Publishing date	2020-12-16
Publishing country	England
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	843037-8
ISSN	1097-0258 ; 0277-6715
ISSN (online)	1097-0258
ISSN	0277-6715
DOI	10.1002/sim.8843
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1756: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: [No title information]

Conti, Catherine / de Thézy, Albane / Leray-Lacagne, Marie-Béatrice

Soins. Gerontologie

2019 Volume 24, Issue 138, Page(s) 45–46

Title translation	40. À propos d’un cas d’angiodermite nécrotique.
MeSH term(s)	Dermatitis/diagnosis ; Humans ; Necrosis/diagnosis ; Vascular Diseases/diagnosis
Language	French
Publishing date	2019-07-15
Publishing country	France
Document type	Case Reports ; Journal Article
ZDB-ID	2246755-5
ISSN	1268-6034
ISSN	1268-6034
DOI	10.1016/j.sger.2019.04.014
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6353: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare Database.

Medioni, Jacques / Scimeca, Daniel / Marquez, Yecenia Lopez / Leray, Emmanuelle / Dalichampt, Marie / Hoertel, Nicolas / Bennani, Mohammed / Trempat, Pascal / Boujedaini, Naoual

Clinical breast cancer

2022 Volume 23, Issue 1, Page(s) 60–70

Abstract: Background: Complementary therapy in oncology aims to help patients better cope with the illness and side effects (SEs) of cancer treatments that affect their quality of life (QOL). This study aimed to assess the benefits of homeopathic treatment on the ...

Abstract	Background: Complementary therapy in oncology aims to help patients better cope with the illness and side effects (SEs) of cancer treatments that affect their quality of life (QOL). This study aimed to assess the benefits of homeopathic treatment on the health-related QOL (HRQOL) of patients with non-metastatic breast cancer (BC) prescribed in postsurgical complementary therapy. Patients and methods: An extraction from the French nationwide healthcare database targeted all patients who underwent mastectomy for newly diagnosed BC between 2012 and 2013. HRQOL was proxied by the quantity of medication used to palliate the SEs of cancer treatments. Results: A total of 98,009 patients were included (mean age: 61 ± 13 years). Homeopathy was used in 11%, 26%, and 22% of patients respectively during the 7 to 12 months before surgery, the 6 months before, and 6 months after. Thereafter, the use remained stable at 15% for 4 years. Six months after surgery, there was a significant overall decrease (RR = 0.88, confidence interval (CI) Conclusion: The study showed an increasing use of homeopathy in patients with BC following diagnosis. This use was maintained after surgery and seemed to play a role in helping patients to better tolerate the SEs of cancer treatments.
MeSH term(s)	Humans ; Middle Aged ; Aged ; Female ; Homeopathy/adverse effects ; Breast Neoplasms/therapy ; Breast Neoplasms/etiology ; Quality of Life ; Retrospective Studies ; Mastectomy/adverse effects ; Delivery of Health Care
Language	English
Publishing date	2022-10-08
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2106734-X
ISSN	1938-0666 ; 1526-8209
ISSN (online)	1938-0666
ISSN	1526-8209
DOI	10.1016/j.clbc.2022.10.001
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5800: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 498: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis.

Mainguy, Marie / Tillaut, Hélène / Degremont, Adeline / Le Page, Emmanuelle / Mainguy, Christelle / Duros, Solène / Polard, Elisabeth / Leray, Emmanuelle

Neurology

2022 Volume 99, Issue 17, Page(s) e1916–e1925

Abstract: Background and objectives: Several studies have shown an increased risk of relapse after in vitro fertilization (IVF) in women with multiple sclerosis (MS), especially when a gonadotrophin-releasing hormone (GnRH) agonist stimulation protocol was used. ... ...

Abstract	Background and objectives: Several studies have shown an increased risk of relapse after in vitro fertilization (IVF) in women with multiple sclerosis (MS), especially when a gonadotrophin-releasing hormone (GnRH) agonist stimulation protocol was used. Our objective was to investigate the risk of relapse after IVF in women with MS, overall and according to stimulation protocol (GnRH agonists vs antagonists), using data from the French national health insurance database. Methods: This retrospective cohort study included all women with MS who have benefited from IVF between January 1, 2010, and December 31, 2015, in France. Three-month exposed periods after IVF were compared with unexposed periods before IVF, each woman being her own control. Four outcomes were considered: annualized relapse rate (ARR), proportion of IVF with relapse, difference in the number of relapses "after-before," and the delay from IVF to the first relapse. Relapses were identified by an algorithm based on MS-related hospital admissions and the use of corticosteroid therapy. Stimulation protocols and disease-modifying therapies (DMTs) were identified using drug claims. Zero-inflated Poisson regression models adjusted for age at IVF and the presence of DMT were used. A random effect on women was included because women may undergo multiple IVF procedures. Subgroup analyses by stimulation protocol and IVF outcome (pregnancy or failure) were conducted. Results: A total of 225 women accounting for 338 IVF procedures were included (the mean age at the first IVF 34.6 ± 4.5 years; 36% of women underwent at least 2 IVF procedures during the period). No increase in the risk of relapse after IVF was found overall (before vs after IVF: 0.20 vs 0.18 relapse per patient-year; 7.7% vs 7.1% of IVF with women having at least one relapse) and in subgroups. A lower ARR before and after IVF was observed among women who remained treated until IVF. Discussion: The maintenance of DMT until IVF seemed to be a determining factor in reducing the risk of relapse. Women with MS should be reassured because we did not show an increased risk of relapse requiring the use of corticosteroid therapy after IVF neither with GnRH agonists nor with GnRH antagonists.
MeSH term(s)	Humans ; Pregnancy ; Female ; Adult ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/etiology ; Retrospective Studies ; Fertilization in Vitro/adverse effects ; Recurrence ; Gonadotropin-Releasing Hormone ; Adrenal Cortex Hormones/therapeutic use
Chemical Substances	Gonadotropin-Releasing Hormone (33515-09-2) ; Adrenal Cortex Hormones
Language	English
Publishing date	2022-10-24
Publishing country	United States
Document type	Journal Article
ZDB-ID	207147-2
ISSN	1526-632X ; 0028-3878
ISSN (online)	1526-632X
ISSN	0028-3878
DOI	10.1212/WNL.0000000000201027
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ui II Zs.153: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MG 18: Show issues
Zs.MO 374: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Prescription patterns of first- and second-generation antipsychotic drugs in the French population.

Kovess-Masfety, Viviane / Balusson, Frédéric / Leray, Emmanuelle / Husky, Mathilde / Scailteux, Lucie-Marie

Fundamental & clinical pharmacology

2020 Volume 34, Issue 5, Page(s) 603–611

Abstract: This study assessed in depth the use of first- and second-generation antipsychotic (FGAP/SGAP) drugs in France. A 1/97th random sample of beneficiaries affiliated to the French Health Insurance system-Echantillon Généraliste des Bénéficiaires (EGB)-was ... ...

Abstract	This study assessed in depth the use of first- and second-generation antipsychotic (FGAP/SGAP) drugs in France. A 1/97th random sample of beneficiaries affiliated to the French Health Insurance system-Echantillon Généraliste des Bénéficiaires (EGB)-was used: (i) 621 662 persons in 2015 among which 11 319 had an antipsychotic (AP) prescription; (ii) a sample of first AP prescriptions concerning 5 935 patients in 2013 and 2014 (no AP in the last 6 months of 2012) for whom diagnosis was available in 40% of cases. In 2015, AP prevalence was 21.9/1 000. SGAP/FGAP ratio was 1.02. Long-lasting prescriptions were rare: 1.79/1 000 for FGAP and 1.38/1 000 for SGAP. FGAP first prescriptions were higher than SGAP for each age class, except for <18 aged patients; 2.85% had both generations; 50.7% of the patients had another psychotropic. GPs prescribed more FGAPs than SGAPs, psychiatrists prescribed more SGAPs and hospital-based practitioners prescribed both generations equally, and these patterns changed across age ranges: For the elderly, GPs are the more frequent prescribers. SGAP/FGAP ratio is different by diagnostic categories. In France, FGAPs are largely prescribed by GPs mainly for the elderly, but young and adult patients are concerned as well. Inappropriate antipsychotic consumption through off-label use, which adds to the co-prescription, especially in vulnerable population groups, mainly concerns FGAP prescriptions by GPs who do not have psychiatric training and limited contact with psychiatrists. Attention should then be brought to the regulatory advisory agencies in order to better inform and train the prescribers.
MeSH term(s)	Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Antipsychotic Agents/therapeutic use ; Female ; France/epidemiology ; Humans ; Insurance Claim Review ; Male ; Middle Aged ; Practice Patterns, Physicians'/statistics & numerical data ; Prevalence ; Young Adult
Chemical Substances	Antipsychotic Agents
Language	English
Publishing date	2020-03-31
Publishing country	England
Document type	Journal Article
ZDB-ID	639134-5
ISSN	1472-8206 ; 0767-3981
ISSN (online)	1472-8206
ISSN	0767-3981
DOI	10.1111/fcp.12553
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2247: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito